Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 23, 2023

SELL
$0.96 - $2.01 $96,000 - $200,999
-100,000 Reduced 21.09%
374,260 $366,000
Q2 2023

Jul 24, 2023

SELL
$1.59 - $2.29 $397,500 - $572,500
-250,000 Reduced 34.52%
474,260 $829,000
Q3 2022

Nov 02, 2022

SELL
$2.6 - $5.12 $260,000 - $512,000
-100,000 Reduced 12.13%
724,260 $2.07 Million
Q1 2022

Apr 26, 2022

SELL
$3.28 - $7.12 $164,000 - $356,000
-50,000 Reduced 5.72%
824,260 $3.16 Million
Q3 2021

Nov 10, 2021

BUY
$7.29 - $11.0 $654,036 - $986,887
89,717 Added 11.44%
874,260 $7.76 Million
Q2 2021

Aug 05, 2021

BUY
$9.87 - $13.32 $7.74 Million - $10.5 Million
784,543 New
784,543 $8.75 Million

Others Institutions Holding ME

About 23andMe Holding Co.


  • Ticker ME
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 259,768,000
  • Market Cap $992M
  • Description
  • 23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...
More about ME
Track This Portfolio

Track Liberty Street Advisors, Inc. Portfolio

Follow Liberty Street Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty Street Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Liberty Street Advisors, Inc. with notifications on news.